We identified ERG as a transcription factor regulating expression of the CITED2 gene, which is specifically overexpressed in prostate cancer, and further clarified the ERG–CITED2 axis as the downstream pathway involved in prostate cancer. This evidence concerns the gene CITED2 and prostate cancer.